Skip to content
Disclosery

EXANE DERIVATIVES: NEE position timeline

Available 13F reports, 13D and 13G stakes and each Form 3, 4 and 5 line of EXANE DERIVATIVES on NEE, newest first. How the timeline and the estimate are built.

EXANE DERIVATIVES held 2,866 NEE shares at 2022-06-30 per its 13F-HR filed 2022-07-12.

the latest 13F is the newest step

  1. period ended2022-06-30
    13F 2,866 shares
    Change vs previous 13F -7,575 shares

    0.13% of the 13F portfolio, value $221,973.

    13F-HR 0001623883-22-000006 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  2. period ended2022-03-31
    13F 10,441 shares
    Change vs previous 13F -2,035 shares

    0.25% of the 13F portfolio, value $884,463.

    13F-HR 0001623883-22-000004 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  3. period ended2021-12-31
    13F 12,476 shares
    Change vs previous 13F +5,183 shares

    0.28% of the 13F portfolio, value $1,164,797.

    13F-HR 0001623883-22-000002 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  4. period ended2021-09-30
    13F 7,293 shares
    Change vs previous 13F +524 shares

    0.14% of the 13F portfolio, value $572,665.

    13F-HR 0001623883-21-000008 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  5. period ended2021-06-30
    13F 6,769 shares
    Change vs previous 13F +3,886 shares

    0.12% of the 13F portfolio, value $506,737.

    13F-HR 0001623883-21-000006 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  6. period ended2021-03-31
    13F 2,883 shares
    Change vs previous 13F -692 shares

    0.07% of the 13F portfolio, value $217,992.

    13F-HR 0001623883-21-000004 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  7. period ended2020-12-31
    13F 3,575 shares
    Change vs previous 13F not available

    0.08% of the 13F portfolio, value $275,821.

    13F-HR 0001623883-21-000002 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).